TY - JOUR
T1 - Increase in circulating ACE-positive endothelial microparticles during acute lung injury
AU - Takei, Yusuke
AU - Yamada, Mitsuhiro
AU - Saito, Koji
AU - Kameyama, Yoshinobu
AU - Sugiura, Hisatoshi
AU - Makiguchi, Tomonori
AU - Fujino, Naoya
AU - Koarai, Akira
AU - Toyama, Hiroaki
AU - Saito, Kazutomo
AU - Ejima, Yutaka
AU - Kawazoe, Yu
AU - Kudo, Daisuke
AU - Kushimoto, Shigeki
AU - Yamauchi, Masanori
AU - Ichinose, Masakazu
N1 - Funding Information:
Support statement: This work was supported by Grants-in-Aid for Scientific Research (15K15562 and 18K08907 to K. Saito, and 15K09206 and 18K08134 to M. Yamada) from the Japan Society for the Promotion of Science ( JSPS). Funding information for this article has been deposited with the Crossref Funder Registry.
Funding Information:
Acknowledgements: We thank Brent K. Bell (Tohoku University Graduate School of Medicine, Sendai, Japan) for critical reading of the manuscript and language assistance. We acknowledge the support of the Biomedical Research Unit of Tohoku University Hospital. We thank M. Kondo (Tohoku University Graduate School of Medicine, Sendai, Japan) for clerical support.
Funding Information:
We thank Brent K. Bell (Tohoku University Graduate School of Medicine, Sendai, Japan) for critical reading of the manuscript and language assistance. We acknowledge the support of the Biomedical Research Unit of Tohoku University Hospital. We thank M. Kondo (Tohoku University Graduate School of Medicine, Sendai, Japan) for clerical support.
Publisher Copyright:
Copyright © ERS 2019
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Circulating endothelial microparticles (EMPs) are considered to be markers of endothelial injury, and lung microvascular endothelial cells express higher levels of angiotensin-converting enzyme (ACE). The aim of this study is to examine whether the number of ACE+ microvascular EMPs could be a prognostic marker for the development of acute respiratory distress syndrome (ARDS) in septic patients. The numbers of EMPs and ACE+ EMPs in the culture supernatant from human microvascular endothelial cells, as well as in the blood of mouse lung injury models and septic patients (n=82), were examined using flow cytometry. ACE+ EMPs in the culture supernatant from pulmonary microvascular endothelial cells increased after exposure to an inflammatory stimulus. In the mouse lung injury models, the circulating ACE+ EMPs and ACE+ EMP/EMP ratio were higher than in the controls (p<0.001). The ACE+ EMP/EMP ratio was correlated with the wet/dry lung ratio (rs=0.775, p<0.001). The circulating ACE+ EMPs and ACE+ EMP/ EMP ratio on admission were significantly increased in septic patients who developed ARDS compared with septic patients who did not (p<0.001). Therefore, circulating ACE+ EMPs may be a prognostic marker for the development of ARDS in the septic patients.
AB - Circulating endothelial microparticles (EMPs) are considered to be markers of endothelial injury, and lung microvascular endothelial cells express higher levels of angiotensin-converting enzyme (ACE). The aim of this study is to examine whether the number of ACE+ microvascular EMPs could be a prognostic marker for the development of acute respiratory distress syndrome (ARDS) in septic patients. The numbers of EMPs and ACE+ EMPs in the culture supernatant from human microvascular endothelial cells, as well as in the blood of mouse lung injury models and septic patients (n=82), were examined using flow cytometry. ACE+ EMPs in the culture supernatant from pulmonary microvascular endothelial cells increased after exposure to an inflammatory stimulus. In the mouse lung injury models, the circulating ACE+ EMPs and ACE+ EMP/EMP ratio were higher than in the controls (p<0.001). The ACE+ EMP/EMP ratio was correlated with the wet/dry lung ratio (rs=0.775, p<0.001). The circulating ACE+ EMPs and ACE+ EMP/ EMP ratio on admission were significantly increased in septic patients who developed ARDS compared with septic patients who did not (p<0.001). Therefore, circulating ACE+ EMPs may be a prognostic marker for the development of ARDS in the septic patients.
UR - http://www.scopus.com/inward/record.url?scp=85073580426&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073580426&partnerID=8YFLogxK
U2 - 10.1183/13993003.01188-2018
DO - 10.1183/13993003.01188-2018
M3 - Article
C2 - 31320458
AN - SCOPUS:85073580426
SN - 0903-1936
VL - 54
JO - Scandinavian Journal of Respiratory Diseases
JF - Scandinavian Journal of Respiratory Diseases
IS - 4
M1 - 01188
ER -